Amber Wouters

2PUBLICATIONS
17CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 18, 2026
GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection.

|Nov 19, 2025
Redosing of anti-CD3 antibodies in NOD mice with new-onset diabetes does not alter the effect of a single treatment course.

Amber Wouters, Pierre Lemaitre, Laure Degroote

Pageof 1

Frequent Collaborators

2 joint publications

Pierre Lemaitre

2 joint publications

Laure Degroote

2 joint publications

Marc Packbier

2 joint publications

Chantal Mathieu